ADPT is trading 5.1% up at $20.33 today. - This follows the company's recent announcement on June 15, 2026, of its plan to separate the Minimal Residual Disease (MRD) and Immune Medicine businesses. - The momentum is also fueled by the pricing of an upsized $300 million convertible senior notes offering on June 17, 2026. - The stock is extending a strong move from June 24, when it closed at $19.34 after a 12.25% jump.